【腎細胞癌】透過機器學習提高「腎細胞癌」臨床預後的預測

 【腎細胞癌】透過機器學習提高「腎細胞癌」臨床預後的預測

 文章出處  

Journal of Clinical Oncology 

 

 原文標題  

An integrative analysis of circulating and tumor microenvironment (TME) determinants of patient response in the Checkmate 9ER (CM 9ER) trial of nivolumab and cabozantinib (NIVO+CABO) in advanced renal cell carcinoma (aRCC). 

 

 文章序號  

8200 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2025 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.